Medifarma-98 Kft.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The Medifarma-98 Kft. site focuses on cardiovascular disease research, exploring innovative treatments to lower the risk of events such as heart attack, stroke, and systemic embolism, especially in patients with atrial fibrillation or atherosclerotic disease.
- Risk reduction for major adverse cardiovascular events
- Evaluation of novel lipid‑modifying agents
- Antithrombotic therapy comparisons
- Primary prevention strategies for atherosclerosis
By enrolling high‑risk participants from Nyíregyháza, the centre aims to bring safer, more effective cardiovascular therapies to the Hungarian community.
Nutritional and Metabolic Diseases
In the field of nutritional and metabolic diseases, the clinic investigates therapies that address obesity and overweight, with an eye on how weight reduction can improve heart health and joint function, including conditions like knee osteoarthritis.
- Weight‑loss interventions and their cardiovascular impact
- Combination studies of metabolic and musculoskeletal outcomes
- New peptide‑based therapies for obesity management
- Patient‑focused strategies for long‑term metabolic health
The research team of three investigators conducts these studies to expand therapeutic options for patients across Europe, while maintaining a strong safety focus.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AstraZeneca AB5active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB10trials
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medifarma-98 Kft.
lock Showing 1 of 33 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Oct 2021 | Jan 2025 |
IMP list
lock Showing 1 of 24 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 5 | Unknown | 2024-06-05 | 2025-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.